Difficulty: Medium
Average Score: 77%
Practice
The treatment of choice for idiopathic pulmonary hemosiderosis (IPH) is:
Correct answer
B
Rationale
The correct answer for the treatment of idiopathic pulmonary hemosiderosis (IPH) is B) systemic corticosteroids. Systemic corticosteroids are the first-line treatment for IPH because they help reduce inflammation in the lungs and suppress the immune response that leads to hemosiderin deposition. Corticosteroids also help to improve lung function and reduce the severity of symptoms in patients with IPH.
Transfusion of blood products (option A) is not the treatment of choice for IPH because it does not address the underlying cause of the disease, which is inflammation and immune dysregulation in the lungs.
Cyclophosphamide (option C) is sometimes used in severe cases of IPH that do not respond to corticosteroids, but it is not typically the first-line treatment due to its potential side effects and toxicity.
Lung transplantation (option D) is considered in very severe cases of IPH where other treatments have failed, but it is not the initial treatment of choice due to the risks associated with transplantation and the availability of other effective treatment options.
Educationally, understanding the rationale behind the treatment of IPH is crucial for nursing care of pediatric patients with respiratory disorders. It is important for nurses to be knowledgeable about the appropriate treatments for different respiratory conditions to provide effective care and improve patient outcomes.
Transfusion of blood products (option A) is not the treatment of choice for IPH because it does not address the underlying cause of the disease, which is inflammation and immune dysregulation in the lungs.
Cyclophosphamide (option C) is sometimes used in severe cases of IPH that do not respond to corticosteroids, but it is not typically the first-line treatment due to its potential side effects and toxicity.
Lung transplantation (option D) is considered in very severe cases of IPH where other treatments have failed, but it is not the initial treatment of choice due to the risks associated with transplantation and the availability of other effective treatment options.
Educationally, understanding the rationale behind the treatment of IPH is crucial for nursing care of pediatric patients with respiratory disorders. It is important for nurses to be knowledgeable about the appropriate treatments for different respiratory conditions to provide effective care and improve patient outcomes.